Efficacy and safety of a once-daily fixed-dose combination of abacavir/lamivudine compared with abacavir twice daily and lamivudine once daily as separate entities in antiretroviral-experienced HIV-1-infected patients (CAL30001 Study).

Efficacy and safety of a once-daily fixed-dose combination of abacavir/lamivudine compared with abacavir twice daily and lamivudine once daily as separate entities in antiretroviral-experienced HIV-1-infected patients (CAL30001 Study).

Item
http://www.wikidata.org/entity/Q51942612
Antiretroviral regimens for patients with HIV who fail first-line antiretroviral therapyAbacavir/lamivudine combination in the treatment of HIV: a review.Safety analysis of Epzicom® (lamivudine/abacavir sulfate) in post-marketing surveillance in JapanAbacavir/lamivudine fixed-dose combination antiretroviral therapy for the treatment of HIV.Spillover adherence effects of fixed-dose combination HIV therapyAbacavir/lamividune combination in the treatment of HIV-1 infection: a review.Lamivudine for the treatment of HIV.Methodological issues in the use of composite endpoints in clinical trials: examples from the HIV field.Lower pill burden and once-daily antiretroviral treatment regimens for HIV infection: A meta-analysis of randomized controlled trials.Systematic review and meta-analysis: Patient and programme impact of fixed-dose combination antiretroviral therapy.Severe myositis on commencement of efavirenz, abacavir and lamivudine, in the absence of lactic acidosis or classical abacavir hypersensitivityShort-term safety and tolerability of a once-daily fixed-dose abacavir-lamivudine combination versus twice-daily dosing of abacavir and lamivudine as separate components: findings from the ALOHA study.
P2860

Efficacy and safety of a once-daily fixed-dose combination of abacavir/lamivudine compared with abacavir twice daily and lamivudine once daily as separate entities in antiretroviral-experienced HIV-1-infected patients (CAL30001 Study).

Item
http://www.wikidata.org/entity/Q51942612
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Efficacy and safety of a once- ...... ted patients (CAL30001 Study).
@en
Efficacy and safety of a once- ...... ienced HIV-1-infected patients
@nl
type
label
Efficacy and safety of a once- ...... ted patients (CAL30001 Study).
@en
Efficacy and safety of a once- ...... ienced HIV-1-infected patients
@nl
prefLabel
Efficacy and safety of a once- ...... ted patients (CAL30001 Study).
@en
Efficacy and safety of a once- ...... ienced HIV-1-infected patients
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P356
P1433
P1476
Efficacy and safety of a once- ...... cted patients (CAL30001 Study)
@en
P2093
P304
P31
P356
10.1097/01.QAI.0000214821.33905.5C
P407
P433
P478
P50
P577
P698